Holen Sie sich die Stockscreener-App
0.1422
6.45%
-0.0098
Handel nachbörslich:
.14
-0.0022
-1.55%
Schlusskurs vom Vortag:
$0.152
Offen:
$0.1504
24-Stunden-Volumen:
1.60M
Relative Volume:
0.22
Marktkapitalisierung:
$1.39M
Einnahmen:
$3.35M
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.018
EPS:
-7.8872
Netto-Cashflow:
$-7.85M
1W Leistung:
-10.00%
1M Leistung:
-45.33%
6M Leistung:
-88.89%
1J Leistung:
-88.80%
1-Tages-Spanne:
$0.138
$0.1542
1-Wochen-Bereich:
$0.138
$0.1654
52-Wochen-Spanne:
$0.138
$3.18
Ispecimen Inc Stock (ISPC) Company Profile
Firmenname
Ispecimen Inc
Sektor
Branche
Telefon
781-301-6700
Adresse
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.1422 | 1.39M | 3.35M | -11.53M | -7.85M | -7.8872 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Ispecimen Inc Aktie (ISPC) Neueste Nachrichten
Bond Watch: Whats the fair value of iSpecimen Inc stock2026 Key Lessons & Intraday High Probability Alerts - baoquankhu1.vn
Heavy losses and going-concern warning at iSpecimen (NASDAQ: ISPC) - Stock Titan
iSpecimen 10-K: Revenue $1.93M, EPS $(2.28) - TradingView
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
iSpecimen Delays Annual Report Filing Briefly - TipRanks
[NT 10-K] iSpecimen Inc. SEC Filing - Stock Titan
Short Covering: What are the future prospects of iSpecimen IncDip Buying & Real-Time Buy Signal Notifications - baoquankhu1.vn
Will iSpecimen Inc benefit from geopolitical trendsQuarterly Trade Summary & Weekly High Return Forecasts - baoquankhu1.vn
ISPC Should I Buy - Intellectia AI
Risk Off: Is iSpecimen Inc subject to activist investor interestWeekly Volume Report & Trade Opportunity Analysis - baoquankhu1.vn
Aug Macro: How does iSpecimen Inc compare to its peersWeekly Stock Recap & Verified Swing Trading Watchlists - baoquankhu1.vn
Trending Industry Today: ISpecimen Leads Losses In SOL Reserve Concept Stocks - Moomoo
Highs Report: Is iSpecimen Inc a good ESG investment2026 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Head to Head Survey: iSpecimen (NASDAQ:ISPC) & XWELL (NASDAQ:XWEL) - Defense World
iSpecimen Inc.Common Stock (NQ: ISPC - The Chronicle-Journal
Aug Patterns: Will iSpecimen Inc benefit from sector rotationWeekly Investment Summary & Consistent Profit Alerts - baoquankhu1.vn
Value Recap: What are the future prospects of iSpecimen IncQuarterly Trade Report & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
iSpecimen collects 500 flu samples, expands specimen network By Investing.com - Investing.com South Africa
iSpecimen collects 500 flu samples, expands specimen network - Investing.com
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research - TMX Newsfile
Stocks Under $1: TOON, ISPC, CXAI, EONR to Watch Now - marketscreener.com
Inside the race to collect 500 flu swabs for critical research - Stock Titan
Buyout Rumor: Will iSpecimen Inc. benefit from geopolitical trends2026 Opening Moves & High Accuracy Swing Entry Alerts - baoquankhu1.vn
iSpecimen Faces Ongoing Shareholder Quorum Challenges for Meeting - The Globe and Mail
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
iSpecimen Inc. (ISPC) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
ISpecimen (ISPC) stock rockets 43% after hours — here's why it's trending - msn.com
iSpecimen Inc. 8-K SEC Filing March 13, 2026 – Company Details, NASDAQ Listing, and Executive Information - Minichart
iSpecimen annual meeting adjourned again due to lack of quorum By Investing.com - Investing.com Canada
iSpecimen annual meeting adjourned again due to lack of quorum - Investing.com
Repeated quorum shortfalls delay iSpecimen (NASDAQ: ISPC) 2025 annual meeting - Stock Titan
Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research - The Globe and Mail
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Benzinga
ISPC: No quorum was present, so the meeting was adjourned without any business or voting - TradingView
Why Is iSpecimen Stock (ISPC) Up Today 3/13/26? - TipRanks
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
iSpecimen (ISPC) Stock Rockets 43% After Hours — Here's Why It's Trending - Benzinga
New AI tool aims to speed scientists' access to human biospecimens - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching - Bluefield Daily Telegraph
Levels Update: Will iSpecimen Inc. stock continue dividend increasesJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - Naître et grandir
Market Recap: Will iSpecimen Inc stock go up in YEAREarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
iSpecimen (ISPC) Expected to Announce Quarterly Earnings on Thursday - Defense World
ISPC SEC FilingsIspecimen Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
ISPC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
iSpecimen (ISPC) Pops on Nano Antibody News: Can The Rally Last? - AD HOC NEWS
ISPC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Ideas: Is iSpecimen Inc stock overvalued or fairly pricedRate Hike & High Accuracy Investment Entry Signals - baoquankhu1.vn
Director Siyun Yang leaves iSpecimen (NASDAQ: ISPC) board role - Stock Titan
Ispecimen Inc. Announces Resignation of Independent Director Siyun Yang, Effective February 17, 2026 - marketscreener.com
Finanzdaten der Ispecimen Inc-Aktie (ISPC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):